ReviewBMJ (Clinical research ed.)
Drug treatment of multiple sclerosis.
Review in BMJ (Clinical research ed.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Ameliorating Effect ofAdvanced biomedical research · 2026Article
- Inflammatory proteins related to depression in multiple sclerosis: A systematic review and meta-analysis.Brain, behavior, & immunity - health · 2025Review
- 2-Bromo-1,4-Naphthalenedione promotes CD8Journal of neuroinflammation · 2024Article
- Immune cells transcriptome-based drug repositioning for multiple sclerosis.Frontiers in immunology · 2022Article
- Oxidative Stress and Lymphocyte Alterations in Chronic Relapsing Experimental Allergic Encephalomyelitis in the Rat Hippocampus and Protective Effects of an Ethanolamine Phosphate Salt.Molecular neurobiology · 2020Article
- Changes in the Multiple Sclerosis Treatment Paradigm. What Do We Do Now and What Were We Doing Before?Journal of clinical neurology (Seoul, Korea) · 2018Article
- Importance of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of the Treatment Efficacy in Multiple Sclerosis Patients with Acute Attacks.Polish journal of radiology · 2015Article
- Blocking A2B adenosine receptor alleviates pathogenesis of experimental autoimmune encephalomyelitis via inhibition of IL-6 production and Th17 differentiation.Journal of immunology (Baltimore, Md. : 1950) · 2013Article
- Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial.Multiple sclerosis international · 2012Article
- Disease modifying agents for multiple sclerosis.The open neurology journal · 2010Article
- Nitric oxide and peroxynitrite in health and disease.Physiological reviews · 2007Review
- FTY720 in multiple sclerosis: the emerging evidence of its therapeutic value.Core evidence · 2006Article
- Review
- Review
- Review
- Drug treatment of multiple sclerosis. Clinical review was unsystematic.BMJ (Clinical research ed.) · 2001Article
Corrections and comments
- Commented on by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.